News + Press

Explore by Category
Select
Abstracts & Publications
Targeted in vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform
June 22, 2023

  Download the poster here.

read more
Abstracts & Publications
Targeted in vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform
June 22, 2023

  Download the poster here.

read more
Press Release
Interius BioTherapeutics Highlights Strong Preclinical Data Supporting In Vivo Chimeric Antigen Receptor (CAR) Vector Evaluation in Clinic
June 21, 2023

PHILADELPHIA, June 21, 2023 /PRNewswire/ — Interius BioTherapeutics, a leading developer of in vivo cell-specific genetic medicine therapeutics, today announced…

read more
Press Release
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
May 09, 2023

PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…

read more
Press Release
Interius BioTherapeutics Hosts Immersive, Hands-on Event to Ignite Students’ Passion for Science
April 27, 2023

Philadelphia, PA – April 27, 2023 – Interius BioTherapeutics, a preclinical stage gene therapy company…

read more
Media Coverage
Ensoma and Interius BioTherapeutics: in vivo veritas
August 26, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Media Coverage
Interius’ Senior Director of Analytical Development to Speak at 14th Annual Bioprocessing Summit
August 17, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Post
The BrightEdge Fund 2021 Annual Review
May 01, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Media Coverage
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Press Release
Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
December 09, 2021

Company also celebrates “Deal of the Year” awarded by The Penn Center for Innovation PHILADELPHIA,…

read more
Media Coverage
Interius Named as Finalist for the Deal of the Year Award by Life Sciences Pennsylvania
December 09, 2021

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more